Delivery Order SPE2DB20D3104-SPE2DB23FV5R2
- Not listed
- This federal contract award is for the delivery of MENVEO A-C-Y-W kits to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, which is a subsidiary of the parent company Cencora, Inc. The contract has a ceiling value of $3,545.50 and a completion date of July 6, 2023. It is a firm fixed-price delivery order contract awarded on July 5, 2023. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen Drug Corp is...
- This federal contract award is for the delivery of MENVEO A-C-Y-W KIT (2 VIALS) to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract has a ceiling value of $3,161.25 and an ultimate completion date of September 25, 2023. The contract is a Delivery Order with a Firm Fixed Price pricing type. This award is not associated with a set-aside designation, indicating it was...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the delivery of MENVEO A-C-Y-W KIT (2 VIALS)S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $3,216.90 and a completion date of July 16, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as the...
- This federal contract award is for the delivery of Menveo A-C-Y-W kits (2 vials) to the Defense Logistics Agency (DLA). The contract has a ceiling value of $18,030.31 and is a firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract has an ultimate completion date of April 24, 2023 and was awarded on April 21, 2023. There is no set-aside designation for this contract. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and...
- This federal contract award is for the delivery of MENVEO A-C-Y-W-135-DIP VIAL KTS, a pharmaceutical product, to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $2,024.34 and is a Firm Fixed Price Delivery Order with a completion date of June 2, 2022. There is no set-aside designation, indicating the contract was awarded through full and open...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of MENVEO A-C-Y-W KIT (2 VIALS) medical products. The award has a ceiling value of $3,216.90 and is a Firm Fixed Price Delivery Order contract, with an ultimate completion date of August 12, 2024. This contract is not set aside for any specific business type. AmerisourceBergen has been awarded numerous federal contracts by various defense...
- This federal contract award is a $3,860.28 firm fixed price delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a for-profit subsidiary of Amerisourcebergen Corporation. The order is for the supply of the MENVEO A-C-Y-W KIT (2 VIALS)S pharmaceutical product, with a completion date of February 5, 2024. Amerisourcebergen Drug Corp serves as the prime contractor on this order, which is not associated with any set-aside designation. The company also holds an...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The award, with a ceiling value of $4,825.35, is for the delivery of 4,564,071,785 MENVEO A-C-Y-W KIT (2 VIALS) and is a firm fixed price delivery order. Amerisourcebergen Drug Corp, through its Corporate Office division, serves as the prime...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the provision of MENVEO A-C-Y-W KIT (2 VIALS)S. The contract, valued at $2,295.33, is a Firm Fixed Price Delivery Order with a period of performance ending on July 11, 2024. Amerisourcebergen, through its Corporate Office division, is the prime contractor and has no set-aside designation for this award. Amerisourcebergen Drug Corp holds a larger...
- This federal contract award is for the delivery of MENVEO A-C-Y-W KIT (2 VIALS) medical supplies to the Department of Defense (DoD) Medical Supply Chain agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, on May 24, 2024 with a ceiling value of $3,216.90. This is a delivery order under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued up to $999,999,999.00...
- SPE2DB20D3104Indefinite Delivery Contract
- SPE2DB20D3104-SPE2DB23FV5R2Delivery Order
This federal contract award is for the delivery of MENVEO A-C-Y-W KIT (2 VIALS) medical supplies to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has a ceiling value of $2,928.70 and a completion date of March 14, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies, particularly the Department of Defense and Department of Veterans Affairs healthcare systems. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for delivering a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific contract award does not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.9k | 3/13/23 |